SMITH SANDFORD D 4
4 · CYTOKINETICS INC · Filed Sep 2, 2022
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
SMITH SANDFORD D
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2022-09-02−3,035→ 0 totalExercise: $10.68From: 2019-06-15Exp: 2029-05-15→ Common Stock (3,035 underlying) - Exercise/Conversion
Common Stock
2022-09-02$10.68/sh+3,035$32,414→ 15,205 total - Exercise/Conversion
Common Stock
2022-09-02$37.89/sh+2,500$94,725→ 23,539 total - Sale
Common Stock
2022-09-02$53.97/sh−11,369$613,585→ 12,170 total - Exercise/Conversion
Common Stock
2022-09-02$24.32/sh+5,834$141,883→ 21,039 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2022-09-02−5,834→ 0 totalExercise: $24.32From: 2021-06-12Exp: 2031-05-12→ Common Stock (5,834 underlying) - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2022-09-02−2,500→ 7,500 totalExercise: $37.89From: 2022-06-10Exp: 2032-05-10→ Common Stock (2,500 underlying)